Citius Pharmaceuticals, Inc. (CTXR)
NASDAQ: CTXR · Real-Time Price · USD
0.835
-0.114 (-11.97%)
At close: Mar 6, 2026, 4:00 PM EST
0.840
+0.005 (0.62%)
After-hours: Mar 6, 2026, 7:57 PM EST
Citius Pharmaceuticals Employees
Citius Pharmaceuticals had 23 employees as of September 30, 2025. The number of employees did not change compared to the previous year.
Employees
23
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$171,483
Profits / Employee
-$1,560,280
Market Cap
18.69M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| IN8bio | 17 |
| Reviva Pharmaceuticals Holdings | 14 |
| VYNE Therapeutics | 13 |
| Genenta Science | 13 |
| Allarity Therapeutics | 7 |
| Intensity Therapeutics | 7 |
| Lexaria Bioscience | 7 |
| NanoViricides | 7 |
CTXR News
- 3 days ago - Citius Oncology Announces Preliminary Topline Phase 1 Data from Study of LYMPHIR™ (E7777) Dosing Prior to Commercial CAR‑T Therapy in High‑Risk Diffuse Large B‑Cell Lymphoma - PRNewsWire
- 11 days ago - Citius Pharmaceuticals, Inc. Secures $3.8 million through New Jersey Economic Development Program - PRNewsWire
- 22 days ago - Citius Oncology, Inc. Announces First Reported Revenue Following Successful Launch of LYMPHIR™ - PRNewsWire
- 22 days ago - Citius Pharmaceuticals, Inc. Announces First Reported Revenue Following Successful Launch of LYMPHIR™ - PRNewsWire
- 24 days ago - Citius Oncology Expands International Distribution of LYMPHIR™ to European Union Through Exclusive Agreement with Uniphar - PRNewsWire
- 2 months ago - Stock Market Today: Dow Jones, S&P 500 Futures Drop On Christmas Eve Despite Strong Q3 GDP Report—UiPath, AST SpaceMobile, Ramaco Resources In Focus - Benzinga
- 2 months ago - Citius Oncology, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business Update - PRNewsWire
- 2 months ago - Citius Pharmaceuticals, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business Update - PRNewsWire